Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine brachial plexus block in severed finger replantation
ChiCTR2300078728Phase 4Not yet recruiting
- Sponsor
- Nanning Second People's Hospital
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bupivacaine and ropivacaine in Traumatic amputation of finger (2 arms), sponsored by Nanning Second People's Hospital. Primary endpoint: Incidence of vascular embolism in replanted fingers. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
Traumatic amputation of finger
Beyond the preview
Go deeper on ChiCTR2300078728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078728.